The purpose of this study was to construct a new typing model for diffuse large B-cell lymphoma (DLBCL) patients based on the B-cell receptor (BCR) and explore its potential molecular mechanism. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.